U.S. Markets closed

Novavax Working Very Hard on Coronavirus Vaccine, R&D President Says

Jan.30 -- Dr. Gregory Glenn, Novavax president of research and development, discusses the efforts to contain the deadly coronavirus. He speaks with Bloomberg's Paul Allen and Taylor Riggs on "Bloomberg Markets."